5S8-32746-20913
2 vaccinations
4 coded responses
21 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 947 / CA
- Registered
- 2021-04-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-15
Registered in v-safe
-
2021-04-15
Dose 1 — Pfizer-BioNTech
- 2021-04-15
-
2021-04-16
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-17
- 2021-04-19
-
2021-04-20
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Good · Joint painsFree text: SnifflesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-21
- 2021-04-22
- 2021-04-29
-
2021-05-06
Dose 2 — Pfizer-BioNTech
-
2021-05-08
Survey response — days 1–6 daily, dose 2MedDRA: Brain fog — Feeling: Good · Site: PainFree text: Brain fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-10
- 2021-05-11
-
2021-05-13
Survey response — day 7, dose 2MedDRA: Heavy menstrual bleeding, Menstruation irregular — Feeling: Fair · Nausea, Abdominal painFree text: Incredibly heavy period bleedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-20
- 2021-05-27
- 2021-06-03
- 2021-06-10
- 2021-06-17
- 2021-08-05
- 2021-11-04
-
2022-05-11
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-05-11
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-15 | Pfizer-BioNTech | |
| 2 | 2021-05-06 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-11 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Sniffles
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Brain fog
Release 8 — day 7, dose 2
Systemic reaction (other): Incredibly heavy period bleeding
Release 11 — 12 months, dose 2
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Brain fog | ✓ | ✓ | ✓ |
| SRO | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SRO | Menstruation irregular | · | · | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release